CDC recommends Novavax for teens aged 12 to 17
The U.S. CDC has recommended the Novavax COVID-19 vaccine for use in children and adolescents aged 12 to 17. The approval follows FDA authorization for a two-dose primary series.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthCDC recommends Novavax for teens aged 12 to 17
Sign in or subscribeBrowse free archive reportsThe U.S. CDC has recommended the Novavax COVID-19 vaccine for use in children and adolescents aged 12 to 17. The approval follows FDA authorization for a two-dose primary series.